Abstract

CLINICAL EVALUATION OF THOTTALVADI CHOORANAM (MIMOSA PUDICA) IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Viswanathan R*, Gnanavel IS, Sivasaravanan KS, Karthikeyan A, Velpandian V

ABSTRACT

Diabetes is a long-term illness that occurs due to the high levels of blood glucose (hyperglycemia). Because our modern lifestyle goes a long way, that more and more people develop type 2 diabetes. So control the blood sugar levels is essential part of healthy life and prevent long-term complications. Thottalvadi Chooranam (Mimosa pudica) is one among the unique Siddha anti-diabetic herbal preparation. So the present open clinical study was conducted and analysed the therapeutic potential of Thottalvadi Chooranam among 50 diabetic patients for the period of six months. Diabetes mellitus can be diagnosed only if the presence of any classical symptoms of diabetes and with FBGL ≥ 140 mg/dl, PPBGL ≥ 250 mg/dl and HbA1C ≥ 6.5. The trial drug was given to all the patients at the dose level of 4gm twice a day with milk for the period of 3 months. At the end of the study period all the above clinical and laboratory parameters along with HbA1C were performed and statistically analyzed. From the result it was observed that the classical clinical signs were improved well. FBGL, PPBGL were significantly reduced from initial readings. It was also observed that 44 patients (88%) had significant reduction in HbA1C when compared with initial reading. The result confirms the therapeutic potential of Siddha herbal drug Thottalvadi Chooranam on type II diabetes mellitus.

Keywords: Diabetes mellitus, Thottalvadi Chooranam, blood glucose level, anti-diabetic activity, HbA1c, Siddha.